Dose-dependent effects of atorvastatin on myocardial infarction.

about

P2860

Q37440382-4E2FCCFB-002A-4481-8BF3-99C20C574B44

P2860

Dose-dependent effects of atorvastatin on myocardial infarction.

Item

http://www.wikidata.org/entity/Q35821913

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Dose-dependent effects of atorvastatin on myocardial infarction.

@ast

Dose-dependent effects of atorvastatin on myocardial infarction.

@en

type

Item

label

Dose-dependent effects of atorvastatin on myocardial infarction.

@ast

Dose-dependent effects of atorvastatin on myocardial infarction.

@en

prefLabel

Dose-dependent effects of atorvastatin on myocardial infarction.

@ast

Dose-dependent effects of atorvastatin on myocardial infarction.

@en

P1476

Dose-dependent effects of atorvastatin on myocardial infarction.

@en

P2860

Acute-phase proteins and other systemic responses to inflammation

Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A

Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes.

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Insulin resistance: cellular and clinical concepts.

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.

Disparity between angiographic regression and clinical event rates with hydrophobic statins.

P304

3361-3368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S86344

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280057723

http://www.w3.org/2001/XMLSchema#string

P698

26170622

http://www.w3.org/2001/XMLSchema#string

P932

4492625

http://www.w3.org/2001/XMLSchema#string

Dose-dependent effects of atorvastatin on myocardial infarction.

about

P2860

P2860

Dose-dependent effects of atorvastatin on myocardial infarction.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932